Combined, the European thermal ablation devices market-including sales derived from generators and energy-based catheters, electrodes/probes, disposables, procedure kits, and accessories used in the treatment of BPH, cancer/tumors, menorrhagia, and chronic venous insufficiency/varicose veins in the countries of France, Germany, Italy, Spain, and the United Kingdom-totaled more than an estimated $250 million. Despite ongoing European economic instability and severe budget constraints, each market segment profiled in this report is expected to increase at conservative yet positive compound annual growth rates over the next five years-ranging from approximately 2.6%-3.3%-due to growing demand, cost-efficiency and efficacy, the gradual adoption of improved, next-generation technologies, and an aging European population susceptible to various diseases/conditions.
This dynamic report from Medtech Insight includes analyses of leading products, markets, competitors, and emerging medical device technologies and opportunities. Covered products in this report include selected specialized energy-based generator systems, medical devices/instruments/accessories for the following minimally invasive or nonsurgical ablation treatment areas: BPH, cancer, chronic venous insufficiency/varicose veins, menorrhagia, as well as selected aesthetic areas, including skin rejuvenation/skin tightening and body sculpting/cellulite/targeted fat reduction. Other applications discussed include treatment of spinal denervation, stress urinary incontinence, and uterine fibroids.
EXECUTIVE SUMMARY i. Overview of Thermal Ablation ii. European Market for Thermal Ablation Devices iii. Methodology Exhibit ES-1: Thermal Effects on Tissue Exhibit ES-2: European Thermal Ablation Devices for Medically Necessary Care, Combined Market Forecast, 2011-2016 Exhibit ES-3: European Thermal Ablation Devices for Medically Necessary Care, Market Forecast, by Treatment Segment, 2011-2016 1. SELECTED EUROPEAN HEALTHCARE MARKETS 1.1 The European Union 1.1.1 A Common Currency 220.127.116.11 The Sovereign Debt Crisis 1.1.2 Late Payments Directive 1.1.3 Regulatory Policies 1.1.4 Reimbursement 1.1.5 Healthcare Spending 1.2 Selected European National Healthcare Profiles 1.2.1 France 18.104.22.168 Healthcare Organization and Reform 22.214.171.124 Hospital Services 126.96.36.199 Medical Services/Supplies Reimbursement 1.2.2 Germany 188.8.131.52 Healthcare Organization and Reform 184.108.40.206 Hospital Services 220.127.116.11 Medical Services/Supplies Reimbursement 1.2.3 Italy 18.104.22.168 Healthcare Organization and Reform 22.214.171.124 Hospital Services 126.96.36.199 Medical Services/Supplies Reimbursement 1.2.4 Spain 188.8.131.52 Healthcare Organization and Reform 184.108.40.206 Hospital Services 220.127.116.11 Medical Services/Supplies Reimbursement 1.2.5 United Kingdom 18.104.22.168 Healthcare Organization and Reform 22.214.171.124 Hospital Services 126.96.36.199 Medical Services/Supplies Reimbursement Exhibit 1-1: European Union, Medical Device Risk Classification System Exhibit 1-2: European Union Population Statistics Comparison for the Years 2000, 2010, and 2020 Exhibit 1-3: France, Selected National Healthcare Statistics Exhibit 1-4: Germany, Selected National Healthcare Statistics Exhibit 1-5: Italy, Selected National Healthcare Statistics Exhibit 1-6: Spain, Selected National Healthcare Statistics Exhibit 1-7: United Kingdom, Selected National Healthcare Statistics 2. THERMAL ABLATION DEVICES OVERVIEW 2.1 Applications for Thermal Ablation 2.1.1 Aesthetics-Skin Rejuvenation and Tightening 188.8.131.52 Alma Lasers 184.108.40.206 Cutera 220.127.116.11 Cynosure 18.104.22.168 Palomar Medical Technologies 22.214.171.124 Solta Medical 126.96.36.199 Syneron Medical 2.1.2 Aesthetics-Body Sculpting, Fat Reduction, and the Reduction in the Appearance of Cellulite 188.8.131.52 Cutera 184.108.40.206 Cynosure 220.127.116.11 Osyris Medical/LSO Medical 18.104.22.168 Solta Medical 22.214.171.124 Syneron Medical 126.96.36.199 Zeltiq Aesthetics 2.1.3 Benign Prostatic Hyperplasia 188.8.131.52 Transurethral Microwave Thermotherapy 184.108.40.206.1 American Medical Systems/ Endo Health Solutions 220.127.116.11.2 Boston Scientific 18.104.22.168.3 ProstaLund Operations 22.214.171.124.4 Urologix 126.96.36.199 Transurethral Needle Ablation 188.8.131.52 Laser- and Other Energy-Based Therapies 184.108.40.206.1 Holmium Laser Ablation/ Enucleation of the Prostate 220.127.116.11.1.1 Lumenis 18.104.22.168.2 Photoselective Vaporization of the Prostate 22.214.171.124.2.1 American Medical Systems/Endo Health Solutions 2.1.4 Cancer/Tumor Ablation 126.96.36.199 Radiofrequency Ablation 188.8.131.52.1 AngioDynamics 184.108.40.206.2 Boston Scientific 220.127.116.11.3 Celsion 18.104.22.168.4 Covidien 22.214.171.124.5 Thermedical 126.96.36.199 Other Ablation Methods 188.8.131.52.1 Cryoablation 184.108.40.206.1.1 Sanarus Technologies 220.127.116.11.2 Microwave Ablation 18.104.22.168.2.1 Covidien 22.214.171.124.2.2 Microsulis Medical and AngioDynamics 126.96.36.199.3 High-Intensity Focused Ultrasound 188.8.131.52.3.1 EDAP TMS 184.108.40.206.3.2 InSightec/Elbit Imaging 2.1.5 Menorrhagia/Endometrial Ablation 220.127.116.11 Boston Scientific 18.104.22.168 CooperSurgical/The Cooper Companies 22.214.171.124 Ethicon/Johnson & Johnson 126.96.36.199 Hologic 2.1.6 Spinal Decompression and Denervation 188.8.131.52 ArthroCare 184.108.40.206 Relievant Medsystems 220.127.116.11 Smith & Nephew 2.1.7 Stress Urinary Incontinence 18.104.22.168 Novasys Medical 2.1.8 Varicose Vein Ablation 22.214.171.124 AngioDynamics 126.96.36.199 CermaVEIN 188.8.131.52 Covidien 2.1.9 Uterine Fibroids 184.108.40.206 InSightec/Elbit Imaging 220.127.116.11 Philips Healthcare/Royal Philips Electronics Exhibit 2-1: Thermal Effects on Tissue Exhibit 2-2: The Accent Radiofrequency Platform Exhibit 2-3: The Pixel CO2 Fractional Laser System and Technology Exhibit 2-4: The Thermage CPT System Exhibit 2-5: Sublative and Sublime Skin Rejuvenation Technologies Exhibit 2-6: The TruSculpt Body Sculpting System Exhibit 2-7: The Cellulaze Cellulite Laser Workstation Exhibit 2-8: The Smartlipo LaserBodySculpting Workstations Exhibit 2-9: The LipoControl GPS Laser Assisted Lipolysis System Exhibit 2-10: A Step-by-Step LipoSonix Procedure Exhibit 2-11: The VelaShape II System Exhibit 2-12: The UltraShape Contour I Body Sculpting System Exhibit 2-13: The CoolSculpting System and Step-by-Step Process Exhibit 2-14: Advantages and Disadvantages of Minimally Invasive Therapy for Benign Prostatic Hyperplasia Exhibit 2-15: The CoreTherm System Exhibit 2-16: Five-Year Clinical Comparison of Symptomatic Reduction in Benign Prostatic Hyperplasia Using the CoreTherm System andCompetitiveTreatments Exhibit 2-17: The CoolWave and Targis Systems Exhibit 2-18: The Cooled ThermCath Advance Catheter Exhibit 2-19: Cooled ThermoTherapy, Selected Five-Year Clinical Trial Results Exhibit 2-20: Comparison of Cooled ThermoTherapy with Drug Therapy, Selected Clinical Results Exhibit 2-21: The Prostiva Radiofrequency Therapy System Exhibit 2-22: Holmium Laser Ablation of the Prostate Using the VersaPulse PowerSuite Laser System Exhibit 2-23: Selected Advantages of Holmium Laser Ablation Using the VersaPulse PowerSuite Compared with Photoselective Vaporization Using the GreenLight PV Exhibit 2-24: The GreenLight High Performance System Exhibit 2-25: The GreenLight Xcelerated Performance System Exhibit 2-26: The MoXy Liquid Cooled Fiber Exhibit 2-27: The Model 1500X Electrosurgical Generator, and StarBurst Xli-Enhanced and Semi-Flex Electrodes Exhibit 2-28: The StarBurst SDE and MRI Electrodes Exhibit 2-29: The NanoKnife Low Energy Direct Current System and Electrode Probes Exhibit 2-30: The RF 3000 Generator and LeVeen Needle Electrode Exhibit 2-31: The Cool-tip RF Ablation System Exhibit 2-32: The Cool-tip RF Ablation System E Series Exhibit 2-33: The HALOFLEX System Exhibit 2-34: The SERF Ablation System Exhibit 2-35: The Visica 2 Treatment System and Step-by-Step Cryoablation Process Exhibit 2-36: The Evident MWA System Exhibit 2-37: The Acculis MTA System and Three-Step Procedure Exhibit 2-38: The Ablatherm Robotic HIFU System Exhibit 2-39: The ExAblate System Exhibit 2-40: Breast Cancer Treatment Using the ExAblate System Exhibit 2-41: The Three-Step Endometrial Ablation Process Using the Genesys Hydro ThermAblator System Exhibit 2-42: The Her Option Cryoablation System Exhibit 2-43: The Gynecare ThermaChoice III Uterine Balloon Therapy System and a Comparison of Selected Outcome Data with Competitive Thermal Ablation Systems Exhibit 2-44: The NovaSure System and Step-by-Step Endometrial Ablation Process Exhibit 2-45: Selected Features of the Next-Generation NovaSure System Exhibit 2-46: Nucleoplasty Using Coblation Technology Exhibit 2-47: Intradiscal Electrothermal Therapy and Targeted Disc Decompression Exhibit 2-48: Renessa Treatment for Stress Urinary Incontinence Exhibit 2-49: The VenaCure EVLT System Exhibit 2-50: The SVS System for the Treatment of Varicose Veins Exhibit 2-51: The Venefit Targeted Endovenous Therapy System Exhibit 2-52: Endovenous Ablation Using the Venefit System Exhibit 2-53: Uterine Fibroid Treatment Using the ExAblate System Exhibit 2-54: Sonalleve Therapy 3. EUROPEAN THERMAL ABLATION DEVICES MARKET 3.1 Procedure Volumes 3.2 Market Forecast 3.3 Competitive Analysis 3.3.1 Benign Prostatic Hyperplasia Ablation 3.3.2 Cancer/Tumor Ablation 3.3.3 Endometrial Ablation 3.3.4 Endovenous Ablation 3.4 Other Thermal Ablation Markets 3.4.1 Aesthetics 18.104.22.168 Body Sculpting/Fat Reduction 3.4.2 Spinal Disc Decompression and Denervation Exhibit 3-1: Europe, Thermal Ablation, Procedure Volumes Forecast, by Type, 2011-2016 Exhibit 3-2: European Thermal Ablation Devices for Medically Necessary Care, Combined Market Forecast, 2011-2016 Exhibit 3-3: European Thermal Ablation Devices for Medically Necessary Care, Market Forecast, by Treatment Segment, 2011-2016 Exhibit 3-4: 2011, European Thermal Ablation Devices Market for Medically Necessary Care, Share of Sales, by Segment Exhibit 3-5: 2016, European Thermal Ablation Devices Market for Medically Necessary Care, Share of Sales, by Segment Exhibit 3-6: 2011, Benign Prostatic Hyperplasia Laser Ablation Products Market, Share by Supplier Exhibit 3-7: 2011, Benign Prostatic Hyperplasia Microwave and Radiofrequency Ablation Products Market, Share by Supplier Exhibit 3-8: 2011, Tumor Ablation Products Market, Share by Supplier Exhibit 3-9: 2011, Endometrial Ablation Products Market, Share by Supplier Exhibit 3-10: 2011, Endovenous Ablation Products Market, Share by Supplier Exhibit 3-11: Leading Nonsurgical Aesthetic Device Companies,Global Revenues, 2010-2011 Exhibit 3-12: 2011, Global Nonsurgical Aesthetic Devices Market, Share by Supplier Exhibit 3-13: 2012, Selected Nonsurgical Body Sculpting/Fat Reduction Systems 4. COMPANY PROFILES 4.1 AngioDynamics, Inc. 4.2 Boston Scientific Corporation 4.3 Covidien PLC 4.4 Endo Health Solutions, Inc. 4.5 Hologic, Inc. 4.6 InSightec LTD/Elbit Imaging LTD 4.7 Johnson & Johnson 4.8 Microsulis Medical LTD 4.9 Solta Medical, Inc. 4.10 Syneron Medical LTD 4.11 Zeltiq Aesthetics, Inc. APPENDIX: COMPANY LISTING